Codiak Presents New Preclinical Data Supporting Development

– Engineered exosome vaccine construct generated durable, comprehensive immunity in vivo – CAMBRIDGE, Mass., April 20, 2022 (GLOBE NEWSWIRE) -- Codiak...

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Washington ,United States ,Codiak Biosciences ,Gaurav Gaiha ,Sriram Sathyanarayanan ,Ragon Institute ,Codiak Biosciences Inc ,World Vaccine Congress ,Nasdaq ,Chief Scientific Officer ,Nasdaq Cdak ,Nc ,Vaccines ,Coronavirus ,Exosomes ,